Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Coagulation Disorders | 2 | 2020 | 105 | 1.130 |
Why?
|
| Hemorrhagic Disorders | 4 | 2022 | 23 | 1.110 |
Why?
|
| Menorrhagia | 4 | 2022 | 81 | 1.080 |
Why?
|
| Pathologists | 1 | 2021 | 26 | 0.710 |
Why?
|
| Gastritis | 2 | 2021 | 372 | 0.700 |
Why?
|
| Telerehabilitation | 1 | 2020 | 10 | 0.670 |
Why?
|
| Hematology | 1 | 2020 | 42 | 0.640 |
Why?
|
| von Willebrand Diseases | 4 | 2022 | 55 | 0.630 |
Why?
|
| Factor V Deficiency | 1 | 2019 | 2 | 0.620 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2019 | 4 | 0.620 |
Why?
|
| Fibrinolysis | 1 | 2019 | 43 | 0.610 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2019 | 50 | 0.600 |
Why?
|
| Gastric Mucosa | 2 | 2021 | 491 | 0.590 |
Why?
|
| Tranexamic Acid | 1 | 2019 | 31 | 0.590 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 275 | 0.590 |
Why?
|
| Antifibrinolytic Agents | 1 | 2019 | 48 | 0.590 |
Why?
|
| Stress, Psychological | 1 | 2020 | 564 | 0.460 |
Why?
|
| Caregivers | 1 | 2020 | 585 | 0.430 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 621 | 0.420 |
Why?
|
| Anxiety | 1 | 2020 | 1030 | 0.400 |
Why?
|
| Parents | 1 | 2020 | 1120 | 0.390 |
Why?
|
| Depression | 1 | 2020 | 1352 | 0.350 |
Why?
|
| Precancerous Conditions | 2 | 2025 | 283 | 0.300 |
Why?
|
| Hemorrhage | 3 | 2022 | 498 | 0.280 |
Why?
|
| Blood Preservation | 2 | 2019 | 29 | 0.270 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2022 | 404 | 0.240 |
Why?
|
| Fatty Liver | 2 | 2025 | 220 | 0.240 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 901 | 0.240 |
Why?
|
| Anus Neoplasms | 1 | 2025 | 43 | 0.230 |
Why?
|
| von Willebrand Factor | 3 | 2022 | 192 | 0.220 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2024 | 20 | 0.220 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2025 | 83 | 0.210 |
Why?
|
| Parietal Cells, Gastric | 1 | 2024 | 38 | 0.210 |
Why?
|
| Neuroendocrine Tumors | 1 | 2024 | 59 | 0.210 |
Why?
|
| Humans | 25 | 2025 | 131781 | 0.180 |
Why?
|
| Papillomavirus Infections | 1 | 2025 | 389 | 0.170 |
Why?
|
| Erythrocytes | 2 | 2019 | 191 | 0.170 |
Why?
|
| Receptors, Estrogen | 1 | 2024 | 723 | 0.170 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2020 | 6 | 0.170 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 11 | 0.170 |
Why?
|
| Cryptosporidiosis | 1 | 2021 | 35 | 0.170 |
Why?
|
| Health Care Surveys | 1 | 2021 | 282 | 0.160 |
Why?
|
| Granulosa Cell Tumor | 1 | 2020 | 38 | 0.160 |
Why?
|
| Point-of-Care Testing | 1 | 2020 | 30 | 0.160 |
Why?
|
| India | 1 | 2020 | 245 | 0.160 |
Why?
|
| Home Care Services | 1 | 2020 | 69 | 0.160 |
Why?
|
| Income | 1 | 2020 | 135 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2025 | 759 | 0.160 |
Why?
|
| Blood Platelets | 2 | 2019 | 318 | 0.160 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2019 | 34 | 0.150 |
Why?
|
| Workload | 1 | 2020 | 154 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 86 | 0.150 |
Why?
|
| Stem Cells | 1 | 2024 | 713 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2020 | 251 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 136 | 0.150 |
Why?
|
| Postpartum Hemorrhage | 1 | 2020 | 111 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2020 | 342 | 0.150 |
Why?
|
| Microfluidics | 1 | 2019 | 30 | 0.150 |
Why?
|
| Diethylnitrosamine | 1 | 2018 | 20 | 0.150 |
Why?
|
| Female | 17 | 2025 | 71221 | 0.150 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2018 | 7 | 0.140 |
Why?
|
| Phenobarbital | 1 | 2018 | 30 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2018 | 65 | 0.140 |
Why?
|
| Plasma | 1 | 2019 | 103 | 0.140 |
Why?
|
| Thrombelastography | 1 | 2019 | 66 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2019 | 132 | 0.140 |
Why?
|
| Erythrocyte Transfusion | 2 | 2019 | 142 | 0.140 |
Why?
|
| Inheritance Patterns | 1 | 2018 | 129 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 2018 | 99 | 0.140 |
Why?
|
| Anemia | 1 | 2022 | 356 | 0.140 |
Why?
|
| Ovary | 1 | 2020 | 361 | 0.140 |
Why?
|
| Prevalence | 2 | 2025 | 2695 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2023 | 724 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 243 | 0.130 |
Why?
|
| Esophageal Mucosa | 1 | 2017 | 12 | 0.130 |
Why?
|
| Down Syndrome | 1 | 2020 | 233 | 0.130 |
Why?
|
| Liver | 1 | 2025 | 1799 | 0.130 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2017 | 66 | 0.130 |
Why?
|
| Mental Health | 1 | 2020 | 384 | 0.130 |
Why?
|
| Spinal Dysraphism | 1 | 2020 | 279 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1948 | 0.120 |
Why?
|
| Esophagoscopy | 1 | 2017 | 175 | 0.120 |
Why?
|
| Metabolome | 1 | 2019 | 329 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 455 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 363 | 0.120 |
Why?
|
| Colonic Polyps | 1 | 2017 | 86 | 0.120 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2015 | 36 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 248 | 0.120 |
Why?
|
| Hemolysis | 1 | 2015 | 86 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 6509 | 0.120 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 772 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 3094 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 442 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2017 | 247 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 265 | 0.110 |
Why?
|
| Adolescent | 6 | 2025 | 20994 | 0.100 |
Why?
|
| Age Factors | 1 | 2020 | 2872 | 0.100 |
Why?
|
| Child | 4 | 2025 | 26316 | 0.100 |
Why?
|
| Barrett Esophagus | 1 | 2017 | 358 | 0.100 |
Why?
|
| Adult | 10 | 2025 | 31710 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 392 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 466 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 1358 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2021 | 1301 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2015 | 536 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 999 | 0.080 |
Why?
|
| Middle Aged | 7 | 2025 | 28897 | 0.080 |
Why?
|
| Male | 8 | 2025 | 65290 | 0.080 |
Why?
|
| Healthy Volunteers | 2 | 2019 | 157 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2025 | 15057 | 0.070 |
Why?
|
| Biopsy | 2 | 2025 | 1252 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4684 | 0.070 |
Why?
|
| Diet | 2 | 2023 | 1119 | 0.060 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2025 | 52 | 0.060 |
Why?
|
| Gastric Acid | 1 | 2024 | 55 | 0.050 |
Why?
|
| Fast Foods | 1 | 2023 | 23 | 0.050 |
Why?
|
| Bile Duct Neoplasms | 1 | 2024 | 131 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2024 | 347 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2023 | 418 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2993 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 418 | 0.040 |
Why?
|
| Metaplasia | 1 | 2021 | 216 | 0.040 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.040 |
Why?
|
| von Willebrand Disease, Type 2 | 1 | 2019 | 4 | 0.040 |
Why?
|
| Plasticizers | 1 | 2019 | 2 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 25 | 0.040 |
Why?
|
| Health Behavior | 1 | 2022 | 390 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2018 | 55 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 66 | 0.040 |
Why?
|
| Diarrhea | 1 | 2021 | 311 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 105 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 313 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 269 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2020 | 205 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 803 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 179 | 0.040 |
Why?
|
| Carcinogens | 1 | 2018 | 129 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 135 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2018 | 240 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 228 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2019 | 192 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 6279 | 0.030 |
Why?
|
| Feces | 1 | 2021 | 725 | 0.030 |
Why?
|
| Exome | 1 | 2022 | 1076 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 274 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 319 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2025 | 1133 | 0.030 |
Why?
|
| Plethysmography | 1 | 2015 | 34 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 866 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 62 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2015 | 82 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1190 | 0.030 |
Why?
|
| Vasodilation | 1 | 2015 | 174 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3838 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1322 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4053 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17667 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2299 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 10102 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3411 | 0.020 |
Why?
|
| Animals | 2 | 2024 | 34402 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 5122 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 10965 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 7575 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 18479 | 0.020 |
Why?
|
| Mutation | 1 | 2020 | 6194 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21263 | 0.010 |
Why?
|